Physician profile
Devon M Anthony
NPI 1649721085
$6,388.12
in general payments reported to CMS, 2019-2025
34 companies · $1,529 in 2025
The $1,529 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,030 · 2022: $951 · 2023: $854 · 2024: $2,024 · 2025: $1,529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,407.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $681.38 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Cvrx, INC. | $624.15 | 2021-2025 | Barostim Neo System |
| Pfizer INC. | $525.75 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $457.90 | 2021-2025 | Lokelma, Farxiga, Wainua |
| Amgen INC. | $454.97 | 2021-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $413.18 | 2021-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $394.94 | 2021-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $349.79 | 2024-2025 | Camzyos |
| Actelion Pharmaceuticals US, INC. | $291.74 | 2021-2025 | Uptravi, Opsumit, Opsynvi |
| Boston Scientific Corporation | $246.11 | 2023-2025 | Watchman Flx |
| Bayer Healthcare Pharmaceuticals INC. | $221.16 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $202.44 | 2021-2025 | |
| Scpharmaceuticals INC. | $195.18 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $187.62 | 2021-2025 | Jardiance |
| Medtronic, INC. | $172.41 | 2023-2024 | Linq II |
Show all 34 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devon Anthony listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.